Trial intelligence / Profile preview

Dexamethasone prophylaxis during stereotactic radiotherapy for brain metastases

ACTRN12615000329561Phase 2Completed

Sponsor
William Buckland Radiotherapy Centre
Start
Apr 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in brain metastases comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Changes or development of symptoms after stereotactic radiotherapy. Started Apr 2015; status: completed.

02

Drugs

dexamethasone
03

Conditions

brain metastases

Beyond the preview

Go deeper on ACTRN12615000329561.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12615000329561.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call